Моисеева О. М., Беркович О. А., Виллевальде С. В., Емельянов И. В. ВЛИЯНИЕ ТЕРАПИИ ЭНАЛАПРИЛОМ НА РАЗВИТИЕ ТРОМБОТИЧЕСКИХ И ВОСПАЛИТЕЛЬНЫХ ИЗМЕНЕНИЙ ПРИ ГИПЕРТОНИЧЕСКОЙ БОЛЕЗНИ. Российский кардиологический журнал. 2005;(4):76-80.
1. Шальнова С.А., Деев А.Д., Оганов Р.Г. и соавт. Роль систолического и диастолического давления для прогноза смертности от сердечно-сосудистых заболеваний//Кардиоваскулярная терапия и профилактика 2002. -№1. -С.10-15.
2. Flack J.M., Neaton J., Grimm R. et al. Blood Pressure and Mortality Among Men With Prior Myocardial Infarction // Circulation. 1995; 92: 2437-2445. JNC-VII: The seventh report of the joint national committee on prevention, detection, evaluation and treatment of high blood pressure // JAMA 2003; 289: 2560-2571.
3. Lip G.Y., Blann A.D. Does hypertension confer a prothrombotic state? Virchow's triad revisited//Circulation. 2000; 101: 218-220.
4. Lip G.Y., Blann A. Von Willebrand factor: a marker of endothelial dysfunction in vascular disorders?//Cardiovasc. Res. 1997; 34: 255 -265.
5. Becker B.F., Heindl В., Kupatt C., Zahler S. Endothelial function and hemostasis//Z. Kardiol. 2000; 89: 160-167.
6. Lip G.Y.H. Target organ damage and the prothrombotic state in hypertension//Hypertension. 2000; 36: 975-977.
7. DeSouza C.A., Dengel D.R., Macko R.F et al. Elevated levels of circulating cell adhesion molecules in uncomplicated essential hypertension//Am. J. Hypertens. 1997; 10: 1335 -1341.
8. Safar M.E., Girerd X., Laurent S. Structural changes of large conduit arteries in hypertension//J. Hypertens. 1996; 14: 545-555.
9. Bots M.L., Hoes A.W, Koudstaal P.J. et al. Common carotid inti-ma-media thickness and the risk of stroke and myocardial infarction: The Rotterdam Study//Circulation. 1997; 96: 1432-1437.
10. Simons P.C., Algra A., Bots M.L. et al. Common carotid intima-media thickness and arterial stiffness: indicators of cardiovascular risk in high-risk patients. The SMART Study (Second Manifestations of ARTerial disease)//Circulation. 1999; 100: 951-957.
11. Sander D., Kukla С., Klingelhofer J. et al. Relationship between circadian blood pressure patterns and progression of early carotid atherosclerosis: A 3-year follow-up study//Circulation. 2000; 102: 1536-1541.
12. HOPE Study Investigators. Effects of an angiotensin -converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients//N. Engl. J. Med. 2000; 342: 145-153.
13. Lonn E.M., Yusuf S., Dzavik V. et al. Effects of ramipril and vitamin E on atherosclerosis.The study to evaluate carotid ultrasound changes in patients treated with Ramipril and vitamin E (SECURE)//Circulation. 2001; 103: 919-925.
14. Тео К.К., Burton J.R., Buller C.E. et al. Long-term effects of cholesterol lowering and angiotensin-converting enzyme inhibition on coronary atherosclerosis.The simvastatin/enalapril coronary atherosclerosis trial (SCAT)//Circulation. 2000;102: 1748-1754.
15. MacMahon S., Sharpe N., Gamble G. et al. Randomized, placebo-controlled trial of the angiotensin-converting enzyme inhibitor, ramipril, in patients with coronary or other occlusive arterial disease. PART-2 Collaborative Research Group. Prevention of Atherosclerosis with Ramipril//J. Am. Coll. Cardiol. 2000; 36: 438-443.
16. Рекомендации по профилактике, диагностике и лечению артериальной гипертензии/Рекомендации экспертов Всероссийского общества кардиологов (ВНОК). 2001.
17. Рогоза А.Н., Никольский В.П., Ощепкова Е.В. и др. Суточное мониторирование артериального давления (Методические вопросы). Под ред. Г.Г. Арабидзе, О.Ю. Атькова. М. 1997.
